Valuation : Treace Medical Concepts, Inc.

Market Cap 299M 258M 243M 221M 416M 28.39B 418M 2.87B 1.12B 14.44B 1.12B 1.1B 47.89B P/E 2026 *
-5.41x
P/E 2027 * -5.94x
Enterprise Value 345M 297M 280M 255M 479M 32.73B 482M 3.31B 1.29B 16.65B 1.29B 1.27B 55.2B EV / Sales 2026 *
1.66x
EV / Sales 2027 * 1.74x
Free-Float
74.43%
Yield 2026 *
-
Yield 2027 * -
1 day-2.13%
1 week-4.37%
Current month-2.13%
1 month+6.73%
3 months+27.78%
6 months+147.31%
Current year+87.76%
1 week 4.4
Extreme 4.405
4.78
1 month 4.25
Extreme 4.25
5.2
Current year 1.17
Extreme 1.17
5.2
1 year 1.17
Extreme 1.17
7.63
3 years 1.17
Extreme 1.17
15.98
5 years 1.17
Extreme 1.17
31.02
10 years 1.17
Extreme 1.17
37.17
Manager TitleAgeSince
Chief Executive Officer 54 2013-06-30
Director of Finance/CFO 56 2020-08-31
Chief Tech/Sci/R&D Officer - 2022-02-28
Director TitleAgeSince
Chairman 54 2025-05-19
Director/Board Member 65 2020-11-19
Director/Board Member 68 2020-11-19
Date Insider Type Main position Quantity % Market Cap. Importance
8/24/26 Buy

Chief Executive Officer

11,000 0.0170%
8/9/26 Tax

Chief Financial Officer

-37,102 0.0572%
8/9/26 Tax

Responsable ventes & marketing

-9,814 0.0151%
Change 5-day change 1-year change 3-year change Capi.($)
-2.13%-4.37%-37.33%-70.46% 306M
-0.16%-0.55%+18.32%+22.13% 12.73B
-0.29%-0.04%+16.03%+27.60% 6.93B
-4.69%-7.77%+38.05%+23.96% 6.26B
+10.66%+18.50% - - 5.69B
+1.85%-1.51%-18.27%+48.13% 5.08B
+0.65%-1.06%-31.11%-21.94% 3.85B
-1.53%-1.36%+40.96%-22.03% 2.06B
+0.83%+4.66%-2.25%+133.91% 1.78B
-1.41%-3.53%+49.76%-13.72% 1.6B
Average +0.38%+2.30%+8.24%+14.18% 4.63B
Weighted average by Cap. +0.75%+1.78%+12.77%+22.98%

Financials

2026 *2027 *
Net sales 207M 179M 168M 153M 288M 19.69B 290M 1.99B 775M 10.02B 779M 762M 33.21B 222M 191M 180M 164M 308M 21.04B 310M 2.13B 828M 10.7B 833M 814M 35.49B
Net income -55.26M -47.67M -44.84M -40.85M -76.82M -5.24B -77.24M -530M -206M -2.67B -207M -203M -8.85B -51.01M -44M -41.39M -37.71M -70.91M -4.84B -71.29M -489M -190M -2.46B -192M -187M -8.17B
Net Debt 45.67M 39.39M 37.05M 33.76M 63.48M 4.33B 63.82M 438M 171M 2.2B 171M 168M 7.31B 86.44M 74.56M 70.14M 63.9M 120M 8.2B 121M 829M 323M 4.17B 325M 317M 13.84B
Logo Treace Medical Concepts, Inc.
Treace Medical Concepts, Inc. is a medical technology company. It is advancing the standard of care for the surgical management of bunion and related midfoot deformities. It has patented the Lapiplasty 3D Bunion Correction System a combination of instruments, implants, and surgical methods designed to surgically correct all three planes of the bunion deformity and secure the unstable joint, addressing the root cause of the bunion and helping patients get back to their active lifestyles. It has Adductoplasty Midfoot Correction System, designed for reproducible surgical correction of midfoot deformities, the SpeedMTP Rapid Compression Implant for addressing bunions through big toe joint fusions, and two systems for minimally invasive osteotomy surgeries: the Nanoplasty 3D Minimally Invasive Bunion Correction System and the Percuplasty Percutaneous 3D Bunion Correction System. It sells its products to physicians, surgeons, ambulatory surgery centers, hospitals, and stocking distributors.
Employees
450
Date Price Change Volume
26-09-01 US$4.600 -2.13% 254,454
26-08-31 US$4.700 +1.08% 260,961
26-08-28 US$4.650 +1.09% 237,099
26-08-27 US$4.600 -2.54% 226,045
26-08-26 US$4.720 -1.87% 217,751
Trader
Investor
-
Global
-
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
5
Last Close Price
4.600USD
Average target price
5.500USD
Spread / Average Target
+19.57%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. TMCI Stock